|
|
Biomarkers Summit 2011 will aim to gather together leading experts from around the globe, to discuss and examine the most pressing issues in the biomarkers industry. The conference, with the theme “Discover, Validation & Qualification”, will provide a great opportunity to get informed about the latest revolutionary biomarker discoveries and clinical research and hear original case studies in the allied field. It will be helpful to learn state-of-the-art techniques to develop a better understanding of the licensing and regulatory issues facing the biomarker industry. The 4th Annual Biomarkers Summit 2011 will cover several key topics, such as: Molecular markers for prostate cancer, Integrating drug and diagnostic development, Anti-IFNa therapy in rheumatic diseases, Somatic mutations as oncology biomarkers, Unlocking Alzheimer’s, Biomarker discovery & validation, Organ specific and general safety biomarkers of compound toxicity, etc.
Visitor Profile
The targeted visitors at the 4th Annual Biomarkers Summit 2011 are Chief Executives, Vice Presidents, Heads, Directors, Scientists and Project Leaders of:
- Regulatory Affairs
- Intellectual Property
- Contract Research
- R&D Process
- Legislation & Policy Advice
- Drug and Safety Assessment
- Biomarker Discovery/Validation
- Diagnostics
- Experimental Medicine
- Early Clinical Development
- Drug Metabolism/Pharmacokinetics
- Clinical Pathology
- Molecular and Cell Biology
- Preclinical Development
- Pharmacokinetics/Pharmacodynamics
- Clinical Pharmacology
- Proteomics/Genomics/Metabolomics
Organizer
SMi Group Ltd
